LXEO
Lexeo Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.76
+4.55%Next report
Analyst consensus
- Next report date
- Dec 14, 2026
- EPS estimate
- -$0.32
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.29
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +13.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $15
- PT range
- $15 – $15
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.29 | -$0.30 | Miss -5.20% | — |
| May 11, 2026 | -$0.29 | -$0.25 | Beat 13.79% | — |
| Mar 30, 2026 | -$0.32 | -$0.27 | Beat 15.62% | — |
| Nov 5, 2025 | -$0.48 | -$0.33 | Beat 31.25% | — |
| Aug 14, 2025 | -$0.64 | -$0.60 | Beat 6.25% | — |
| Mar 24, 2025 | -$0.87 | -$0.78 | Beat 10.34% | — |
| Nov 13, 2024 | -$0.65 | -$0.89 | Miss -36.92% | — |
| May 9, 2024 | -$0.76 | -$0.77 | Miss -1.32% | — |
| Mar 11, 2024 | -$0.73 | -$0.85 | Miss -16.44% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 14, 2026